Cytogel Pharma specializes in innovative pain relief solutions through the development of endomorphin peptides. These novel therapeutics aim to address existing limitations in pain management by providing safe and effective alternatives in the biotechnology and pharmaceutical sectors.
Specialties
Endomorphin-based pain relief
First-in-class drug development
Innovative peptide therapeutics
Targeting key pain pathways
Safe alternatives to opioids
Products & Services
Endomorphin Peptide Therapies
Pain Management Solutions
Novel Drug Candidates
Biopharmaceutical Development
Clinical Stage Therapeutics
Contact Information
No contact information available
Competitors & Similar Companies(7)
Acorda Therapeutics
New York, • United States
Amgen
California, • United States
SOBI
Stockholm, • Sweden
Zymeworks
British Columbia, • Canada
AcelRx Pharmaceuticals
California, • United States
Intercept Pharmaceuticals
New York, • United States
Eton Pharmaceuticals
Illinois, • United States
News & Media
Search Terms:
cytogel pharma
Search Topics:
AcquisitionAI: Product LaunchInvestment: Approval FundingProject: Bid and AuctionBusiness ExpansionFinancing and FundraisingInvestmentJoint VentureLeadership Change (CXO)MergerPartnershipProduct LaunchPublic Offering (IPO)RebrandingReorganizationRestructuringValuation
Competitors of Cytogel Pharma are Acorda Therapeutics, Amgen, SOBI, Zymeworks, AcelRx Pharmaceuticals, Intercept Pharmaceuticals, Eton Pharmaceuticals.
What does Cytogel Pharma do?
Cytogel Pharma specializes in innovative pain relief solutions through the development of endomorphin peptides. These novel therapeutics aim to address existing limitations in pain management by providing safe and effective alternatives in the biotechnology and pharmaceutical sectors.
What are the social media links of Cytogel Pharma?